ask="N/A"
ask_size="N/A"
average_daily_volume="82163"
bid="N/A"
bid_size="N/A"
book_value="2.84"
change="N/A"
change_from_200_day_moving_average="-1.72"
change_from_50_day_moving_average="-0.20"
change_from_52_week_high="-4.19"
change_From_52_week_low="0.20"
change_in_percent="N/A"
close="2.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="10701000"
high="N/A"
high_52_weeks="6.39"
last_trade_date="2/13/2017"
last_trade_price="2.20"
last_trade_size="N/A"
last_trade_time="3:59pm"
low="N/A"
low_52_weeks="2.00"
market_capitalization="46.65M"
moving_average_200_day="3.92"
moving_average_50_day="2.40"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-43.93%"
percent_change_from_50_day_moving_average="-8.47%"
percent_change_from_52_week_high="-65.57%"
percent_change_from_52_week_low="+10.00%"
previous_close="2.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.76"
stock_exchange="NMS"
symbol="SBBP"
volume="0"
weeks_range_52="2.00 - 6.39"
